Krista Feind, PA
Physician Assistant · Washington, DCNPI 1508518853
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $576 and has fallen 71.9% since, to $162 in 2025.
Across 41 payments — averaging $27.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$215
- GSK$93
- Immunogen, Inc.$91
- Johnson & Johnson$73
- Astellas Pharma US Inc$73
- Ardelyx, Inc.$63
- plus $523 from 17 others
What the payments were for
- Food & beverage$1,131100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 6 | $215 |
| GSK | 2 | $93 |
| Immunogen, Inc. | 1 | $91 |
| Johnson & Johnson | 3 | $73 |
| Astellas Pharma US Inc | 3 | $73 |
| Ardelyx, Inc. | 3 | $63 |
| Merck | 2 | $56 |
| Ipsen Biopharmaceuticals, Inc | 2 | $54 |
| Sanofi | 2 | $51 |
| AbbVie | 2 | $48 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $39 |
| Ferring Pharmaceuticals Inc. | 2 | $36 |
| Celltrion USA Inc. | 1 | $32 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Medtronic | 1 | $25 |
| Exelixis Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| QOL Medical, LLC | 1 | $21 |
| Stemline Therapeutics Inc. | 1 | $21 |
| Pfizer | 1 | $20 |
| Braintree Laboratories, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Intercept Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$1,131 in reported general payments places this provider in the 80th percentile of 372 physician assistant providers in District of Columbia.
See all physician assistant providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other physician assistant in Washington
- Shana PermanWashington$36K
- Keriann KupermanWashington$24K
- Harleen BathWashington$18K
- Dustin FronczakWashington$13K
- Irena CulicWashington$13K
- Catherine UgliettaWashington$9K
- Milajurine LindsayWashington$9K
- Joseph HudsonWashington$8K
- Sonia BahrooWashington$7K
- Ryan WierWashington$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.